{"product_id":"global-breast-biopsy-market-core-needle-vacuum-assisted-fine-needle-aspiration-insights-forecast-with-potential-impact-of-covid-19-2023-2027","title":"Global Breast Biopsy Market (Core Needle, Vacuum Assisted \u0026 Fine Needle Aspiration): Insights \u0026 Forecast with Potential Impact of COVID-19 (2023-2027)","description":"\u003cp\u003eGlobal Breast Biopsy Market (Core Needle, Vacuum Assisted \u0026amp; Fine Needle Aspiration): Insights \u0026amp; Forecast with Potential Impact of COVID-19 (2023-2027)\u003cbr\u003e\nThe global breast biopsy market is forecasted to reach US$1.90 billion in 2027, experiencing growth at a CAGR of 8.72% for the period spanning 2023-2027. Growth in the global breast biopsy market was supported by factors such as increasing prevalence of breast cancer and rising female population aged 65 or above. Growing adoption of liquid biopsy is likely to have a positive impact on the global breast biopsy market. However, the market growth is expected to be restrained by increasing possibility of infection associated with breast biopsy procedure.\u003c\/p\u003e \n\n\u003cp\u003eThe global breast biopsy market by type can be segmented into the following segments: core needle biopsy (CNB), vacuum assisted biopsy (VAB) and fine needle aspiration biopsy (FNAB). In 2022, the dominant share of global breast biopsy market was held by core needle biopsy (CNB), followed by vacuum assisted biopsy (VAB). The global breast biopsy market by image guided technology can be segmented as follows: mammography guided stereotactic biopsy, ultrasound guided biopsy, MRI guided biopsy and CT guided biopsy. The largest share of the market was held by mammography guided stereotactic biopsy, followed by ultrasound guided biopsy and MRI guided biopsy.\u003c\/p\u003e \n\n\u003cp\u003eThe global breast biopsy market by region can be segmented into the following segments: North America, Europe and Asia Pacific. In 2022, the dominant share of market was held by North America, followed by Europe and Asia Pacific. Factors such as rising elderly female population, growing awareness regarding early detection of breast cancer and increasing income of the consumers helped in boosting market growth.\u003c\/p\u003e  \n\n\u003cp\u003eScope of the report:\u003c\/p\u003e\n\n\u003cp\u003eThe report provides a comprehensive analysis of the global breast biopsy market with potential impact of COVID-19.\u003c\/p\u003e\n\n\u003cp\u003eThe major regional markets (North America, Europe and Asia Pacific) have been analyzed.\u003c\/p\u003e \n\n\u003cp\u003eThe market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.\u003c\/p\u003e \n\n\u003cp\u003eThe company profiles of leading players (Hologic, Danaher Corporation, Becton, Dickinson \u0026amp; Company, Roche Group, Medtronic and Qiagen) are also presented in detail.\u003c\/p\u003e\n\n\u003cp\u003eKey Target Audience:\u003c\/p\u003e\n\n\u003cp\u003eBreast Biopsy Manufacturers\u003c\/p\u003e\n\n\u003cp\u003eRaw Material Providers\u003c\/p\u003e\n\n\u003cp\u003eEnd Users (Businesses\/Consumers)\u003c\/p\u003e\n\n\u003cp\u003eInvestment Banks\u003c\/p\u003e\n\n\u003cp\u003eGovernment Bodies \u0026amp; Regulating Authorities\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"July, 2023 \/ 71 Pages \/ MCW16237499","offer_id":47652478189874,"sku":null,"price":1680.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-breast-biopsy-market-core-needle-vacuum-assisted-fine-needle-aspiration-insights-forecast-with-potential-impact-of-covid-19-2023-2027","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}